These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1389908)

  • 21. Immunotoxin therapy of malignancy.
    Grossbard ML; Nadler LM
    Important Adv Oncol; 1992; ():111-35. PubMed ID: 1582669
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of antibodies or their fragments for the treatment of tumors].
    Douillard JY; Chatal JF
    Bull Cancer; 1998 Nov; 85(11):951-9. PubMed ID: 9951422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Future prospects of monoclonal antibodies as magic bullets in immunotherapy.
    Maleki LA; Baradaran B; Majidi J; Mohammadian M; Shahneh FZ
    Hum Antibodies; 2013; 22(1-2):9-13. PubMed ID: 24284304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal antibodies as carriers of toxins.
    Uhr JW; Fulton RJ; Till MA; May RD; Vitetta ES
    Prog Clin Biol Res; 1989; 288():403-12. PubMed ID: 2785694
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunotoxin: from the idea of "magic bullets" to clinical applications].
    Engert A; Thorpe P
    Med Klin (Munich); 1990 Sep; 85(9):555-60. PubMed ID: 2233614
    [No Abstract]   [Full Text] [Related]  

  • 26. Human anti-mouse IgM and IgG responses in ovarian cancer patients after radioimmunotherapy with 90Y-muHMFG1.
    Oei AL; Sweep FC; Geurts-Moespot A; van Tienoven D; Von Mensdorff-Pouilly S; Thomas CM; Massuger LF
    Anticancer Res; 2008; 28(5A):2721-5. PubMed ID: 19035301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antibodies as specific tumor therapy agents. Wishful thinking or reality?].
    Gramatzki M; Valerius T
    Internist (Berl); 1997 Nov; 38(11):1055-62. PubMed ID: 9453954
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antibody-conjugated cytostatic drugs. Uses of monoclonal antibodies for new strategies in tumor therapy].
    Renner C; Pfreundschuh M
    Fortschr Med; 1994 Oct; 112(29):399. PubMed ID: 8001887
    [No Abstract]   [Full Text] [Related]  

  • 29. Interleukin-2 receptor-directed therapies: antibody- or cytokine-based targeting molecules.
    Strom TB; Kelley VR; Murphy JR; Nichols J; Woodworth TG
    Adv Nephrol Necker Hosp; 1994; 23():347-56. PubMed ID: 8154364
    [No Abstract]   [Full Text] [Related]  

  • 30. Targeted cancer treatment.
    Goldenberg DM
    Immunol Today; 1989 Sep; 10(9):286-8. PubMed ID: 2590380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiolabeled monoclonal antibody being studied as "vaccine" in ovarian cancer patients.
    Oncology (Williston Park); 1993 May; 7(5):57. PubMed ID: 8512783
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of ricin A chain-containing immunotoxins directed against the CD30 antigen as potential reagents for the treatment of Hodgkin's disease.
    Engert A; Burrows F; Jung W; Tazzari PL; Stein H; Pfreundschuh M; Diehl V; Thorpe P
    Cancer Res; 1990 Jan; 50(1):84-8. PubMed ID: 2152774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies.
    Blumenthal RD; Sharkey RM; Haywood L; Natale AM; Wong GY; Siegel JA; Kennel SJ; Goldenberg DM
    Cancer Res; 1992 Nov; 52(21):6036-44. PubMed ID: 1394228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cooperative mixtures of bispecific F(ab')2 antibodies for delivering saporin to lymphoma in vitro and in vivo.
    French RR; Courtenay AE; Ingamells S; Stevenson GT; Glennie MJ
    Cancer Res; 1991 May; 51(9):2353-61. PubMed ID: 2015599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibody therapy for cancer.
    von Mehren M; Adams GP; Weiner LM
    Annu Rev Med; 2003; 54():343-69. PubMed ID: 12525678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotherapy of cancer.
    Harris DT; Mastrangelo MJ
    Semin Oncol; 1989 Jun; 16(3):180-98. PubMed ID: 2658082
    [No Abstract]   [Full Text] [Related]  

  • 37. Antibody therapy of malignancy.
    Dyer MJ
    Eur J Cancer; 1992; 28(1):276-80. PubMed ID: 1567679
    [No Abstract]   [Full Text] [Related]  

  • 38. [New developments in therapy of non-Hodgkin lymphomas with monoclonal antibodies].
    Buske C; Feuring-Buske M; Unterhalt M; Hiddemann W
    Dtsch Med Wochenschr; 1999 Jul; 124(27):842-7. PubMed ID: 10432945
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of monoclonal antibodies in the immunotherapy of neoplasms].
    Robak T
    Przegl Lek; 1989; 46(4):420-6. PubMed ID: 2672121
    [No Abstract]   [Full Text] [Related]  

  • 40. Cancer biotherapy: 1993 to the millenium and more!
    Oldham RK
    Cancer Biother; 1993; 8(1):1-2. PubMed ID: 7812343
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.